Safety of mRNA-COVID-19 Vaccines in Patients With Thoracic Cancers.

ABSTRACT:

Background

Pivotal trials of COVID-19 vaccines did not include cancer patients with questions remaining in this population. Particularly in patients with thoracic malignancies receiving anticancer treatments, the safety of these vaccines has so far been little investigated.

Methods

This is a prospective trial of patients with thoracic cancer receiving anticancer treatments and COVID-19 vaccines at the Division of Thoracic Oncology of European Institute of Oncology between February and September 2021.

Results

A total 207 patients affected by thoracic cancers (199 lung cancers and 8 mesotheliomas) had received Covid-19 vaccines (206 mRNA vaccines and 1 virus-vectored vaccine). The majority of patients had at least one comorbidity (76.3%). They were concomitantly treatin

SUBMITTER: Spitaleri G 

PROVIDER: S-EPMC9584758 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature